Innova has always been an important player in the life sciences space, and their outstanding contributions to flow cytometry (FACS) technology have made them leaders in this field. FACS technology provides superior multiparametric cell analysis capabilities at the single-cell level, and Innova Biologics, with its advanced instrumentation and comprehensive solutions, provides critical support for scientists in cell research and immunology.
Highly flexible multi-parameter analysis
Our FACS technology platform is known for its highly flexible, multiparametric analysis. By using a multi-channel laser and fluorescent label probing system, this technology allows researchers to analyze multiple cell markers simultaneously in a single experiment, providing a more comprehensive and in-depth characterization of cells. Whether it's in immunophenotyping, cell cycle studies, or stem cell research, ModelBio's FACS technology provides researchers with precise and efficient tools.
Wide range of applications
Our FACS technology is not only suitable for basic scientific research, but also for a wide range of applications in drug development, immunology**, and clinical diagnostics. Their instruments and kits cover a wide range of cell types and research directions, providing researchers with flexibility and comprehensive options. The company also works with its clients to provide personalized solutions to meet the needs of different research projects.
Data accuracy and instrument stability
ModelBio focuses on data accuracy and instrument stability for its FACS technology. Their instruments are designed and manufactured to the highest standards, ensuring the reliability of experimental results. At the same time, the quality control kits and standard operating procedures (SOPs) provided by the company help ensure the consistency and reproducibility of experiments.
Customer training and technical support
As a company focused on customer satisfaction, ModelBio not only provides high-quality instruments and reagents, but also provides comprehensive customer training and technical support. Their team of professionals ensures that users are able to use the full potential of FACS technology and solve problems that may arise during their experiments through training courses and regular updates.
Continuous innovation and collaboration
We are committed to continuous innovation in the field of FACS technology. They work closely with partners in academia and industry to drive continuous technological advancements. Through this continuous innovation and collaboration, we ensure that our FACS technology remains at the forefront of scientific research.
Conclusion
Through its excellence in FACS technology, Innova Biosciences provides scientists with advanced and reliable tools to advance the field of cell research and immunology. Their highly flexible multi-parameter analysis techniques and relentless spirit of innovation have made them an indispensable leader in the field of FACS technology.
About ModelBio: Chuangmo Biotechnology (Beijing)** was founded by scientists from Novo Nordisk China R&D Center, CrownBio, and the Institute of Immunology of Shanghai Jiao Tong University. With a stable humanized mouse model platform for the immune system (HIS) and a humanized tumor xenograft platform (PDX) in China, Chuangmo Biosciences focuses on the field of tumor and tumor immunopharmacodynamics CRO services, translational medicine research services, and personalized medicine, serving new drug R&D enterprises, translational medicine researchers, and cancer patients, and is committed to providing a new generation of clinical experimental animal models for the research and development of tumor and tumor immunity.
ModelBio**:
*：news/52.html